ArticleNature medicine2018
Predicting progression to AML.
Article in Nature medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Clinical management of clonal hematopoiesis.Cancer · 2026Review
- Article
- Clinicopathologic characteristics and outcomes of patients with clonal hematopoiesis who progress to myeloid neoplasms.Leukemia · 2025Article
- Multiparameter prediction of myeloid neoplasia risk.Nature genetics · 2023Article
- CRISPR/dCas9 DNA methylation editing is heritable during human hematopoiesis and shapes immune progeny.Proceedings of the National Academy of Sciences of the United States of America · 2023Article
- Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.Current oncology reports · 2023Review
- CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023Review
- Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.Cold Spring Harbor molecular case studies · 2023Review
- [Diagnostics in unclear cytopenia-How and when do we screen for clonal hematopoiesis?]Innere Medizin (Heidelberg, Germany) · 2022Review
- Article
- NPM1 gene mutations can be confidently identified in blood DNA months before de novo AML onset.Blood advances · 2022Article
- Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease.Nature reviews. Cardiology · 2020Review
- Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week.Journal of the American College of Cardiology · 2019Review
- Getting personal with myelodysplastic syndromes: is now the right time?Expert review of hematology · 2019Review
Corrections and comments
- Comment on
- Comment on
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
29988142What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.